| Not Yet Recruiting | Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice Breast Cancer, Metastatic, Metastatic Breast Cancer | N/A | 2026-06-01 |
| Not Yet Recruiting | Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary Cancer of Unknown Primary | Phase 2 | 2026-06-01 |
| Not Yet Recruiting | Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (T Triple Negative Breast Cancer (TNBC) | — | 2026-04-08 |
| Recruiting | Novel Treatment of Radiation Associated Dysphagia With Statins Radiation-associated Dysphagia, Head &Amp; Neck Cancer | Phase 2 | 2025-12-05 |
| Recruiting | Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellul Leukemia, CART Therapy, Transplantation, Stem Cell | N/A | 2025-12-03 |
| Recruiting | A Study to Describe the Effect of Photobiomodulation (Low Level Laser Therapy) in Reducing the Severity and In Oral Mucositis | N/A | 2025-11-26 |
| Active Not Recruiting | EQUIP - Evaluation of Quality of Imaging on a Next-generation Total Body Pet Scan in Comparison to Conventiona Cancer | N/A | 2025-11-24 |
| Not Yet Recruiting | Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metas Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Phase 1 | 2025-11-01 |
| Recruiting | IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma Melanoma (Skin Cancer) | — | 2025-09-11 |
| Not Yet Recruiting | Home-Based Photo-Biomodulation for Management of Lymphoedema and Radiation Fibrosis in Patients After Head and Head and Neck Cancer | N/A | 2025-09-04 |
| Recruiting | Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanu Chronic Lymphocytic Leukemia | Phase 2 | 2025-05-05 |
| Recruiting | MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymph Relapsed/Refractory Large B-cell Lymphoma | Phase 2 | 2024-05-14 |
| Recruiting | Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy Oligometastatic Prostate Cancer | Phase 2 | 2023-12-14 |
| Recruiting | CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecul Extramedullary Myeloma | Phase 1 | 2023-12-08 |
| Recruiting | Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions Invasive Fungal Infections | — | 2023-12-01 |
| Active Not Recruiting | Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Mantle Cell Lymphoma Refractory | Phase 2 | 2023-09-07 |
| Recruiting | Metabolic Phenotypes in Melanoma Melanoma | N/A | 2023-06-27 |
| Active Not Recruiting | Deep sequencIng in Cutaneous Squamous CEll caRciNomas Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Neoplasms | Phase 2 | 2023-05-26 |
| Suspended | Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer Metastatic Castration Resistant Prostate Cancer (mCRPC) | Phase 1 | 2022-10-21 |
| Recruiting | EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2022-09-29 |
| Active Not Recruiting | Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cance Metastatic Castration-resistant Prostate Cancer, MCRPC, Prostate Cancer | Phase 1 / Phase 2 | 2022-09-13 |
| Active Not Recruiting | Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer, mCRPC | Phase 1 / Phase 2 | 2022-07-14 |
| Recruiting | Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Inherited BMF Syndrome, Inherited Platelet Disorder, Hematologic Diseases | — | 2022-03-18 |
| Active Not Recruiting | PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI Prostate Cancer | Phase 3 | 2022-03-02 |
| Unknown | A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Cancer | Phase 2 | 2022-02-24 |
| Unknown | FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary Cancer of Unknown Primary Site | N/A | 2022-02-23 |
| Recruiting | NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma Renal Cell Carcinoma, Clear Cell, Somatic | Phase 2 | 2022-02-08 |
| Completed | Invasive Fungal Infections in Patients Following Stem Cell Transplant Invasive Fungal Infections, Stem Cell Transplant Complications | — | 2022-01-15 |
| Recruiting | PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study NSCLC | Phase 1 | 2022-01-03 |
| Recruiting | PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours Neuroendocrine Tumors | Phase 1 | 2021-12-08 |
| Unknown | Perioperative Pharmacogenomic Testing Pharmacogenetics, Anesthesia | N/A | 2021-11-29 |
| Terminated | Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study Cancer | N/A | 2021-09-23 |
| Active Not Recruiting | Hepatocellular Carcinoma Imaging Using PSMA PET/CT Hepatocellular Carcinoma | Phase 2 | 2021-09-08 |
| Active Not Recruiting | A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma | Phase 1 / Phase 2 | 2021-06-29 |
| Unknown | The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders. Bone Marrow Failure Syndrome, Aplastic Anemia | — | 2021-06-09 |
| Recruiting | ProsTIC Registry of Men Treated With PSMA Theranostics Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | — | 2021-05-01 |
| Unknown | Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer Metastatic Triple Negative Breast Cancer | Phase 2 | 2021-03-01 |
| Completed | COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; Cancer, Covid19, Respiratory Viral Infection | Phase 3 | 2020-12-17 |
| Active Not Recruiting | Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy Prostatic Neoplasms | Phase 1 / Phase 2 | 2020-08-06 |
| Terminated | Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial Colonic Cancer, Rectal Cancer, Non Small Cell Lung Cancer | Phase 3 | 2020-07-31 |
| Unknown | Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE Melanoma, Metastasis | Phase 1 / Phase 2 | 2020-06-04 |
| Active Not Recruiting | In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treat Metastatic Hormone Naive Prostate Cancer | Phase 2 | 2020-04-21 |
| Active Not Recruiting | Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantl Mantle Cell Lymphoma Recurrent | Phase 2 | 2020-04-07 |
| Active Not Recruiting | Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer Breast Neoplasm Female | Phase 1 | 2019-09-25 |
| Active Not Recruiting | Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma Follicular Lymphoma | Phase 1 / Phase 2 | 2019-08-19 |
| Completed | PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr) Metastatic Castration Resistant Prostate Cancer | Phase 1 / Phase 2 | 2019-07-12 |
| Active Not Recruiting | 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer Metastatic Castration Resistant Prostate Cancer (mCRPC) | Phase 1 | 2019-07-09 |
| Unknown | A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma Hodgkin Lymphoma | Phase 2 | 2018-11-29 |
| Completed | Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hodgkin Lymphoma | Phase 1 | 2018-08-30 |
| Completed | MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial Colorectal Cancer, Adenoid Cystic Carcinoma | Phase 1 | 2018-08-22 |
| Completed | Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer Breast Cancer | Phase 2 | 2018-08-01 |
| Unknown | BEACON - ABC in Recurrent Platinum Resistant HGSOC Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | Phase 2 | 2018-07-10 |
| Completed | High Intensity Functional Image Guided Vmat Lung Evasion Non Small Cell Lung Cancer Stage III | N/A | 2018-07-01 |
| Completed | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer Rectal Cancer | Phase 2 | 2018-04-30 |
| Completed | PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Haematopoietic Stem Cell Transplant, Autologous | N/A | 2018-01-08 |
| Terminated | Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Non-small Cell Lung Cancer | Phase 1 | 2017-12-07 |
| Completed | Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study Cancer, Breast, Cancer Colorectal, Cancer Prostate | Phase 4 | 2017-08-27 |
| Terminated | A Study of APR-246 in Oesophageal Cancer Oesophageal Carcinoma | Phase 1 / Phase 2 | 2017-04-11 |
| Completed | A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours Advanced Cancer | Phase 1 | 2016-11-24 |
| Completed | Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours Renal Cell Carcinoma | Phase 1 / Phase 2 | 2016-10-20 |
| Completed | Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer Metastatic Breast Cancer | Phase 2 | 2015-09-07 |
| Completed | Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 An Breast Neoplasms, Bone Neoplasms | Phase 1 | 2015-09-01 |
| Completed | NMP in Relapsed / Refractory Myeloma Multiple Myeloma | Phase 1 | 2015-08-20 |
| Unknown | ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM) Mantle Cell Lymphoma | Phase 2 | 2015-07-22 |
| Terminated | A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL) Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma | Phase 2 | 2012-10-01 |
| Completed | Panobinostat Biological Correlates Study Nodal Lymphoma, Lymphoma With Cutaneous Involvement, Lymphoma in Leukemic Phase | Phase 2 | 2012-07-16 |
| Completed | A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metast Cancer | N/A | 2012-05-01 |
| Terminated | Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies Squamous Cell Carcinoma | EARLY_Phase 1 | 2011-10-01 |
| Completed | A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), Wi Myelodysplastic Syndromes (MDS), Acute Myeloid Leukaemia (AML) | Phase 2 | 2010-12-01 |
| Unknown | Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Sy Multiple Myeloma, Acute Myeloid Leukaemia, Myelodysplastic Syndrome | Phase 1 | 2010-01-01 |
| Completed | A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Multiple Myeloma | Phase 2 | 2007-06-01 |
| Unknown | Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia Myelodysplasia | EARLY_Phase 1 | 2007-02-01 |
| Unknown | A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2006-11-01 |
| Completed | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer Rectal Cancer | Phase 2 | 2006-10-01 |
| Completed | Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse Multiple Myeloma | Phase 2 | 2006-06-01 |
| Completed | A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimul Multiple Myeloma, Lymphoma | Phase 1 / Phase 2 | 2005-10-01 |
| Completed | ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells Multiple Myeloma, Cutaneous Lymphoma | Phase 1 | 2005-03-01 |
| Completed | Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Sta Cervical Cancer | Phase 1 | 2004-12-01 |
| Unknown | Androgen Deprivation Therapy in Treating Patients With Prostate Cancer Prostate Cancer | Phase 3 | 2004-10-01 |
| Completed | A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer Malignant Rectal Neoplasm, Recurrent Tumor | Phase 2 | 2004-07-01 |